AnaptysBio Inc buy UBS Group AG
Start price
13.05.26
/
50%
€54.40
Target price
13.05.27
-
Performance (%)
-12.35%
Price
16.07.26
€47.68
Summary
This prediction is currently active. The prediction for AnaptysBio Inc disappoints with a performance of -12.35%. This prediction currently runs until 13.05.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | -17.059% | -17.059% |
| iShares Core DAX® | -1.087% | 0.196% |
| iShares Nasdaq 100 | -2.463% | -1.792% |
| iShares Nikkei 225® | -5.371% | -5.434% |
| iShares S&P 500 | -0.197% | 1.767% |
Comments by UBS_Group_AG for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for ANAB provided by MarketBeat